You are here

The Newly Issued Shares of Bristol-Myers Squibb Company are Listed on the CFD Instruments Under the BMY Ticker

22.11.2019

We draw the attention of the customers concluding CFDs on shares of the US companies that instead of the ticker CELG (Celgene Corporation, NASDAQ: CELG) starting on December 2, 2019, the ticker BMY (Bristol-Myers Squibb Company, NYSE: BMY) will appear in the Forex Optimum Group trading terminal. Under the ticker BMY, the newly issued shares of Bristol-Myers Squibb Company will be traded.

Note that in the official release of the Bristol-Myers Squibb Company on November 20, 2019, it announced the completion of the transaction for the purchase of Celgene Corporation. As a result, Celgene became a subsidiary of the Bristol-Myers Squibb Company, and stock trading with the CELG symbol on the exchange was stopped on November 20, 2019.

The Bristol-Myers Squibb Company will forcefully close all remaining CELG positions at the last quote on November 26, between 18:00 and 21:00 server time, after which the symbol will be put into closed mode. At the same time, all trading reports on the CELG instrument will remain available. Instead of the CELG ticker, the company will open the BMY (Bristol-Myers Squibb Company) ticker for trading, trading on it will be open starting on December 2, 2019.